Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
Matthew Franklin 49 President and Chief Operating Officer Anil Jina, MB, BCh, BAO 51 Chief Medical Officer Jacqueline Studer, J.D. 63 Chief Legal Officer Jonathan David . 44 Chief Product Officer Non-Executive Directors: Chamath Palihapitiya 46 Chairman and Director Bharatt Chowrira, J.D., Ph.D. 57 Director Kenneth Ehlert 53 Director Adam Gazzaley, M.D., Ph.D. 53 Director William “BJ” Jones, Jr. 59 Director Christine Lemke 45 Director Executive officers W. Edward (“Eddie”) Martucci, Ph.D. , one of Akili’s co-founders, has served as our Chief Executive Officer, and as a member of our board of directors since August 2022. Dr. Martucci served in the same capacity at Akili from August 2015 until August 2022, including as Akili’s employee beginning in September 2017. From June 2009 to September 2017, Dr. Martucci was employed by PureTech Health PLC, a publicly traded biotherapeutics company, where he co-founded Akili in 2011 and served as Akili’s Chief Operating Officer from 2011 until August 2015.
This record is keyed to SEC CIK 0001936491 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 82 institutional-holder rows on these vehicles, under 34 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.